Intelligent Bio Solutions Inc. (INBS) intrinsic value & 10-year financials
Intelligent Bio Solutions Inc. (INBS) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue grew 74.5% a year to $3.1M, with an average return on invested capital of -248.0%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.50
- Market cap
- $7.9M
- Revenue (FY2025)
- $3.1M
- Revenue growth (7-yr CAGR)
- 74.5%
- ROIC (10-yr avg)
- -248.0%
- Free cash flow (FY2025)
- -$9.9M
INBS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $3.1M | -$10.6M | -$2.00 | -$9.9M | -348.7% | -501.7% |
| FY2024 | $3.1M | -$10.2M | -$6.38 | -$9.6M | -330.5% | -430.0% |
| FY2023 | $1.3M | -$10.6M | -$10.58 | — | -1002.1% | -406.1% |
| FY2022 | $437.1K | -$8.3M | -$11.33 | — | -1907.1% | -76.6% |
| FY2021 | $2.0M | -$7.0M | — | — | -281.4% | -142.6% |
| FY2020 | $188.7K | -$3.2M | — | — | -1513.7% | 69.1% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
INTELLIGENT BIO SOLUTIONS INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
INTELLIGENT BIO SOLUTIONS INC. has historically struggled to out-earn its cost of capital, averaging just -27.3% ROIC.
INTELLIGENT BIO SOLUTIONS INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, INTELLIGENT BIO SOLUTIONS INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-66.43 per share.